APA

Hellemans R., Hazzan M., Durand D., Mourad G., Lang P., Kessler M., Charpentier B., Touchard G., Berthoux F., Merville P., Ouali N., Squifflet J., Bayle F., Wissing K. M., Noël C. & Abramowicz D. (20160628). Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study. : American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Chicago

Hellemans R, Hazzan M, Durand D, Mourad G, Lang P, Kessler M, Charpentier B, Touchard G, Berthoux F, Merville P, Ouali N, Squifflet J-P, Bayle F, Wissing K M, Noël C and Abramowicz D. 20160628. Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study. : American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Harvard

Hellemans R., Hazzan M., Durand D., Mourad G., Lang P., Kessler M., Charpentier B., Touchard G., Berthoux F., Merville P., Ouali N., Squifflet J., Bayle F., Wissing K. M., Noël C. and Abramowicz D. (20160628). Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study. : American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

MLA

Hellemans R, Hazzan M, Durand D, Mourad G, Lang P, Kessler M, Charpentier B, Touchard G, Berthoux F, Merville P, Ouali N, Squifflet J-P, Bayle F, Wissing K M, Noël C and Abramowicz D. Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study. : American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 20160628.